AI Assistant
Blog
Pricing
Log In
Sign Up
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.